{"title":"对与结核分枝杆菌有关的发病机制、流行病学和危险因素的包容性认识","authors":"M. Dwivedi, M. Bhat, Aiswarya R.K.","doi":"10.2174/1573398x18666220501133152","DOIUrl":null,"url":null,"abstract":"\n\nTuberculosis is one of the most common and oldest human afflictions caused by the deadly pathogen, Mycobacterium tuberculosis. Its infection drastically increasing worldwide with time despite the application of various antibiotics and live attenuated vaccines. The major risk factor associated with tuberculosis is the long-term malfunction of the respiratory system that increases the deaths whereas the continuous emergence of drug-resistant MTB strains (MDR/TDR/XDR) acts as a driving force to accelerate additional obstacles to humankind. Researchers are effortlessly involved in a systematic examination of tuberculosis and drug designing against it but still, we could not find a permanent cure for tuberculosis. Therefore, it is extremely necessary to analyse pathogenesis, epidemiology and associated risk factors to plan an overall strategy against this deadly disease. In the present study, we have gone through a comprehensive literature survey to provide all related information that may assist us understanding this disease and designing strategic planning. This study would fill the gap created due to lack of knowledge on MTB infection and molecular mechanism which is the biggest hurdle in finding out a therapeutic lead against tuberculosis.\n","PeriodicalId":44030,"journal":{"name":"Current Respiratory Medicine Reviews","volume":" ","pages":""},"PeriodicalIF":0.2000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"An inclusive perception on pathogenesis, epidemiology and risk factors associated with Mycobacterium Tuberculosis\",\"authors\":\"M. Dwivedi, M. Bhat, Aiswarya R.K.\",\"doi\":\"10.2174/1573398x18666220501133152\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nTuberculosis is one of the most common and oldest human afflictions caused by the deadly pathogen, Mycobacterium tuberculosis. Its infection drastically increasing worldwide with time despite the application of various antibiotics and live attenuated vaccines. The major risk factor associated with tuberculosis is the long-term malfunction of the respiratory system that increases the deaths whereas the continuous emergence of drug-resistant MTB strains (MDR/TDR/XDR) acts as a driving force to accelerate additional obstacles to humankind. Researchers are effortlessly involved in a systematic examination of tuberculosis and drug designing against it but still, we could not find a permanent cure for tuberculosis. Therefore, it is extremely necessary to analyse pathogenesis, epidemiology and associated risk factors to plan an overall strategy against this deadly disease. In the present study, we have gone through a comprehensive literature survey to provide all related information that may assist us understanding this disease and designing strategic planning. This study would fill the gap created due to lack of knowledge on MTB infection and molecular mechanism which is the biggest hurdle in finding out a therapeutic lead against tuberculosis.\\n\",\"PeriodicalId\":44030,\"journal\":{\"name\":\"Current Respiratory Medicine Reviews\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.2000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Respiratory Medicine Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/1573398x18666220501133152\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"RESPIRATORY SYSTEM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Respiratory Medicine Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1573398x18666220501133152","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
An inclusive perception on pathogenesis, epidemiology and risk factors associated with Mycobacterium Tuberculosis
Tuberculosis is one of the most common and oldest human afflictions caused by the deadly pathogen, Mycobacterium tuberculosis. Its infection drastically increasing worldwide with time despite the application of various antibiotics and live attenuated vaccines. The major risk factor associated with tuberculosis is the long-term malfunction of the respiratory system that increases the deaths whereas the continuous emergence of drug-resistant MTB strains (MDR/TDR/XDR) acts as a driving force to accelerate additional obstacles to humankind. Researchers are effortlessly involved in a systematic examination of tuberculosis and drug designing against it but still, we could not find a permanent cure for tuberculosis. Therefore, it is extremely necessary to analyse pathogenesis, epidemiology and associated risk factors to plan an overall strategy against this deadly disease. In the present study, we have gone through a comprehensive literature survey to provide all related information that may assist us understanding this disease and designing strategic planning. This study would fill the gap created due to lack of knowledge on MTB infection and molecular mechanism which is the biggest hurdle in finding out a therapeutic lead against tuberculosis.
期刊介绍:
Current Respiratory Medicine Reviews publishes frontier reviews on all the latest advances on respiratory diseases and its related areas e.g. pharmacology, pathogenesis, clinical care, and therapy. The journal"s aim is to publish the highest quality review articles dedicated to clinical research in the field. The journal is essential reading for all researchers and clinicians in respiratory medicine.